Richard K. Sterling
Virginia Commonwealth University
317 Papers
1.7K Citations
Richard K. Sterling is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Medicine & Hepatitis C. The author has an hindex of 67, co-authored 274 publications. Previous affiliations of Richard K. Sterling include VCU Medical Center.
Chat about Author
Papers
Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.
Nevin Yilmaz,Mitchell L. Shiffman,R. Todd Stravitz,Richard K. Sterling,Velimir A. Luketic,Arun J. Sanyal,Daniel G. Maluf,Adrian Coterell,Marc P. Posner,Robert A. Fisher +9 more
TL;DR: It is concluded that recurrence of HBV following LT can be prevented in E‐antigen‐positive patients with a combination of HBIG and an anti‐viral agent, and in contrast, recurrence can be prevent in E-antigen-negative patients with H BIG alone.
29
Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfection.
Richard K. Sterling,Mary S Wilson,Arun J. Sanyal,Velimir A. Luketic,R. Todd Stravitz,Melissa J. Contos,A. Scott Mills,Mitchell L. Shiffman +7 more
TL;DR: In this uncontrolled retrospective analysis, it was unable to show a significant impact of either PI or NNRTI use on the spectrum of liver disease.
29
Treatment of fulminant hepatic failure with intravenous prostaglandin E1
TL;DR: It is apparent that PGE1 was not effective for treatment of FHF if treatment started more than 10 days after onset of this clinical syndrome, and early recognition and hospitalization is the most important factor in reduction of mortality from FHF.
28
Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection.
Ashwin Balagopal,Hyon S. Hwang,Tanner Grudda,Jeffrey Quinn,Richard K. Sterling,Mark S. Sulkowski,Chloe L. Thio +6 more
TL;DR: It is concluded that cccDNA transcription is reduced in HIV/HBV co-infected people with longer antiviral duration, which may be critical to develop a functional cure.
28
Comparison of three commercially available assays for HCV RNA using the international unit standard: Implications for management of patients with chronic hepatitis C virus infection in clinical practice
Mitchell L. Shiffman,Andrea Ferreira-Gonzalez,K. Rajender Reddy,Richard K. Sterling,Velimir A. Luketic,R. Todd Stravitz,Arun J. Sanyal,Carleton T. Garrett,Maria De Medina,Eugene R. Schiff +9 more
TL;DR: Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice are compared.
27